相关实验视频
Updated: Sep 10, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
[意大利法布里病心血管注册局的现状和项目]
Elena Biagini1, Giuseppe Limongelli2, Vanda Parisi1
1U.O.C. Cardiologia, Dipartimento Cardio-Toraco-Vascolare, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna - European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart).
这是一种罕见的遗传性疾病, 一个新的注册表旨在改善对这些患者心血管症状的了解和护理.
科学领域:
- 遗传学和罕见疾病
- 心血管医学
- 代谢性疾病
更多相关视频
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease III: Clinical Manifestations

